Johnson S - Search Results

1

Chromosome abnormalities involving band 13q14 in hematologic malignancies.

Fitchett M, Griffiths MJ, Oscier DG, Johnson S, Seabright M. Fitchett M, et al. Among authors: johnson s. Cancer Genet Cytogenet. 1987 Jan;24(1):143-50. doi: 10.1016/0165-4608(87)90091-4. Cancer Genet Cytogenet. 1987. PMID: 3491671

2

An 8;14 translocation in a case of plasma cell leukemia.

Copplestone JA, Oscier DG, Johnson S. Copplestone JA, et al. Among authors: johnson s. Leuk Res. 1987;11(7):655-9. doi: 10.1016/0145-2126(87)90039-7. Leuk Res. 1987. PMID: 3613649

3

Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations.

Mufti GJ, Hamblin TJ, Oscier DG, Johnson S. Mufti GJ, et al. Among authors: johnson s. Blood. 1983 Nov;62(5):1142-6. Blood. 1983. PMID: 6605167 Free article.

4

Waldenström's macroglobulinaemia.

Johnson SA, Oscier DG, Leblond V. Johnson SA, et al. Blood Rev. 2002 Sep;16(3):175-84. doi: 10.1016/s0268-960x(02)00016-4. Blood Rev. 2002. PMID: 12163003 Review.

5

Splenic marginal zone lymphoma.

Oscier D, Owen R, Johnson S. Oscier D, et al. Among authors: johnson s. Blood Rev. 2005 Jan;19(1):39-51. doi: 10.1016/j.blre.2004.03.002. Blood Rev. 2005. PMID: 15572216 Review.

6

Response to cladribine in previously treated patients with chronic lymphocytic leukaemia identified by ex vivo assessment of drug sensitivity by DiSC assay.

Bosanquet AG, Copplestone JA, Johnson SA, Smith AG, Povey SJ, Orchard JA, Oscier DG. Bosanquet AG, et al. Among authors: johnson sa. Br J Haematol. 1999 Aug;106(2):474-6. doi: 10.1046/j.1365-2141.1999.01581.x. Br J Haematol. 1999. PMID: 10460608 Free article. Clinical Trial.

7

Guidelines on the management of Waldenström macroglobulinaemia.

Johnson SA, Birchall J, Luckie C, Oscier DG, Owen RG; Haemato-Oncology Task Force of the British Committee for Standards in Haematology. Johnson SA, et al. Br J Haematol. 2006 Mar;132(6):683-97. doi: 10.1111/j.1365-2141.2005.05948.x. Br J Haematol. 2006. PMID: 16487169 Free article. Review. No abstract available.

8

Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.

Foran JM, Oscier D, Orchard J, Johnson SA, Tighe M, Cullen MH, de Takats PG, Kraus C, Klein M, Lister TA. Foran JM, et al. Among authors: johnson sa. J Clin Oncol. 1999 May;17(5):1574-9. doi: 10.1200/JCO.1999.17.5.1574. J Clin Oncol. 1999. PMID: 10334546 Clinical Trial.

9

Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.

Johnson SA, Owen RG, Oscier DG, Leblond V, Levy V, Jaeger U, Seymour JF. Johnson SA, et al. Clin Lymphoma. 2005 Mar;5(4):294-7. doi: 10.3816/clm.2005.n.020. Clin Lymphoma. 2005. PMID: 15794869 Clinical Trial.

10

The bioavailability of oral fludarabine phosphate is unaffected by food.

Oscier D, Orchard JA, Culligan D, Cunningham D, Johnson S, Parker A, Klein M, Gieschen H. Oscier D, et al. Among authors: johnson s. Hematol J. 2001;2(5):316-21. doi: 10.1038/sj.thj.6200113. Hematol J. 2001. PMID: 11920267 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,296 results

Search Page

Filters